Department of Radiation Oncology
The Brody School of Medicine at East Carolina University
600 Moye Blvd.
Greenville, NC 27834
Phone (252) 744-2900 / Fax (252) 744-2812
M.D., University of North Carolina at Chapel Hill, NC, 1995
Internship: University of North Carolina at Chapel Hill, NC, 1996
Radiation Oncology Residency: University of North Carolina at Chapel Hill, NC, 2000
Board Certification
Board Certified Radiation Oncologist by the American Board of Radiology, 2000
Clinical Services
Gastrointestinal tumors (for example, cancer of the pancreas, esophagus, stomach, and rectum)
Thoracic tumors (for example, lung cancer)
Pediatric Oncology
Sarcomas
Brachytherapy
Image Guided Radiation Therapy (IGRT)
Intensity Modulated Radiation Therapy (IMRT)
Stereotactic radiosurgery and radiotherapy
Gamma Knife radiosurgery
Research Interests
Clinical and translational research in gastrointestinal, thoracic, sarcoma, and pediatric cancer Selected Publications
Saif MW, Black G, Roy S, Bell D, Russo S, Eloubeidi MA, Steg A, Johnson MR, Zelterman D, Diasio RB. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase. Cancer J. 2007 Jul-Aug;13(4):247-56.
Russo S, Butler J, Ove R, Blackstock AW. Locally advanced pancreatic cancer: a review. Semin Oncol. 2007 Aug;34(4):327-34.
Steg A, Wang W, Blanquicett C, Grunda JM, Eltoum IA, Wang K, Buchsbaum DJ, Vickers SM, Russo S, Diasio RB, Frost AR, LoBuglio AF, Grizzle WE, Johnson MR. Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn. 2006 Feb;8(1):76-83.
Dobelbower MC, Russo SM, Raisch KP, Seay LL, Clemons LK, Suter S, Posey J, Bonner JA. Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study. Anticancer Drugs. 2006 Jan;17(1):95-102.
Blanquicett C, Saif MW, Buchsbaum DJ, Eloubeidi M, Vickers SM, Chhieng DC, Carpenter MD, Sellers JC, Russo S, Diasio RB, Johnson MR. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8773-81.
Saif MW, Eloubeidi MA, Russo S, Steg A, Thornton J, Fiveash J, Carpenter M, Blanquicett C, Diasio RB, Johnson MR. Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. J Clin Oncol. 2005 Dec 1;23(34):8679-87.
Saif MW, Black G, Johnson M, Russo S, Diasio R. Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase. Cancer Chemother Pharmacol. 2006 Dec;58(6):771-5. Epub 2006 Mar 22.
Russo SM, Ove R. Molecular targets as therapeutic strategies in the management of breast cancer. Expert Opin Ther Targets. 2003 Aug;7(4):543-57.
